List of works by Marco Colleoni

A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer.

scientific article published on 13 May 2010

A randomized phase II trial comparing preoperative plus perioperative chemotherapy with preoperative chemotherapy in patients with locally advanced breast cancer.

scientific article published in November 2006

A randomized phase II trial of two different schedules of mitomycin C and vinorelbine in pretreated breast cancer

scientific article published on 01 September 1997

A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer

scientific article published on 29 June 2012

A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer.

scientific article published on 13 February 2009

Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials.

scientific article published on 04 April 2016

Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT

scientific article published on 16 October 2019

Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer

scientific article published on 23 January 2017

Activity of combination chemotherapy in brain metastases from breast and lung adenocarcinoma.

scientific article

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.

scientific article published on 28 March 2016

Adjuvant chemotherapy in breast cancer: back to the future.

scientific article published in April 2003

Adjuvant endocrine therapy for premenopausal women with early breast cancer.

scientific article

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

scientific article

Adjuvant ovarian suppression in premenopausal breast cancer

scientific article

Adjuvant systemic therapies for patients with breast cancer: endocrine responsiveness and effects of chemotherapy.

scientific article

Adjuvant therapies for special types of breast cancer.

scientific article published on October 2011

Adjuvant therapy for very young women with breast cancer: response according to biologic and endocrine features.

scientific article published in June 2004

Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials.

scientific article published on 02 October 2013

Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.

scientific article

Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group.

scientific article published on 13 July 2007

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.

scientific article published on 19 January 2016

Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype

article

Assessment of response in primary chemotherapy for breast cancer

scientific article published on 01 October 1998

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial

scientific article published on 11 March 2013

Benefits and adverse effects of endocrine therapy

scientific article

Bone scan had no role in the staging of 765 consecutive operable T1–2N0–1 breast cancer patients without skeletal symptoms

scientific article published on 01 May 2001

Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors

scientific article published on 06 November 2006

Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients.

scientific article

Breast phyllodes tumor: a review of literature and a single center retrospective series analysis

scientific article published on 17 July 2013

Breast-conserving surgery in 201 very young patients (<35 years)

scientific article published on 26 November 2009

Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?

scientific article published on 6 April 2011

Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.

scientific article published on 12 November 2007

Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy.

scientific article published on 19 November 2014

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study

scientific article published on 13 February 2017

Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy

scientific article published on 16 March 2006

Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

scientific article

Clinical overview of metronomic chemotherapy in breast cancer.

scientific article published on 04 August 2015

Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution.

scientific article

Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer: still a question?

scientific article published on 01 February 1998

Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT.

scientific article published in September 2017

Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

scientific article published on 01 March 2020

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

scientific article published on 01 August 2017

Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF.

scientific article published on June 2002

Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93

scientific article published on 11 April 2007

Erratum to: Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters: Is it Oncologically Safe? A Matched-Cohort Analysis

scientific article published on 22 February 2016

Estimation of historical control rate for a single arm de-escalation study - Application to the POSITIVE trial

scientific article published on 02 June 2020

Evaluation of Ki-67 expression as a prognostic feature in hepatocellular carcinoma in cirrhosis

scientific article published on 01 January 1995

Evidence of responsiveness to chemotherapy in aggressive Rosai-Dorfman disease

scientific article published on 01 January 1995

Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy.

scientific article published on 6 November 2007

Extended adjuvant chemotherapy in endocrine non-responsive disease

scientific article published on August 2013

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

scientific article published on 17 November 2017

Factor v leiden mutation in patients with breast cancer with a central venous catheter: risk of deep vein thrombosis

scientific article published on 01 January 2006

Feasibility of paclitaxel in a patient with anthracycline-induced congestive heart failure

scientific article published on 01 February 1997

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

article

Focusing on physical function limitations in elderly women surviving cancer: any opportunity for improvement?

scientific article published on 01 November 2006

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind

scientific article

Goserelin in Premenopausal Advanced Breast Cancer: Clinical and Endocrine Evaluation of Responsive Patients

scientific article published on 01 May 1994

Guidelines on the standards for the training of specialised health professionals dealing with breast cancer

article

HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17

scientific article published on 12 September 2007

HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH?

scientific article published on 12 March 2012

Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (CMF regimen)

scientific article published on 01 November 1999

Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome.

scientific article published on 24 October 2012

Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up?

scientific article published on 26 March 2013

Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.

scientific article published on 6 August 2011

Immunohistochemically defined subtypes and outcome of apocrine breast cancer

scientific article

Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial

scientific article published on 8 November 2016

Impact of SERM adherence on treatment effect: International Breast Cancer Study Group Trials 13-93 and 14-93.

scientific article

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease

scientific article published on 9 June 2015

Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required?

scientific article published on 01 January 2000

Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy

scientific article

Influence of margin status on outcomes in lobular carcinoma: experience of the European Institute of Oncology.

scientific article published in March 2011

Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.

scientific article published in March 2009

Innovation in care and research: meeting highlights from the seventh Milan Breast Cancer Conference (Milan, 15-17 June, 2005)

scientific article published on 01 April 2006

Intermittent Letrozole Administration as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer: A Biologic Study

scientific article published on 30 April 2015

International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?

scientific article

Intra-arterial chemotherapy followed by chemo-embolisation in unresectable hepatocellular carcinoma.

scientific article published on January 1997

Introducing taxanes in the adjuvant treatment of breast cancer: expectations and reality

scientific article published on 01 June 2000

Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity

scientific article published on 7 October 2008

Invasive lobular breast cancer: subtypes and outcome.

scientific article

Investigation of 18F-FDG PET in the selection of patients with breast cancer as candidates for sentinel node biopsy after neoadjuvant therapy.

scientific article published on 10 June 2010

Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93

scientific article

Lack of prognostic significance of “classic” lobular breast carcinoma: a matched, single institution series

Lapatinib and metronomic capecitabine combination in an HER2-positive inflammatory breast cancer patient: a case report.

scientific article published on 23 December 2009

Lesson learned from high-dose chemotherapy for high-risk breast cancer (What you see is what you mean).

scientific article published in February 2004

Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan

scientific article

Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant setting.

scientific article published on October 2009

Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.

scientific article published on 10 March 2008

Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer.

scientific article published on 8 January 2011

Lobular Metastatic Breast Cancer Patients With Gastrointestinal Involvement: Features and Outcomes

scientific article published on 10 July 2017

Local therapy for breast cancer in malignant lymphoma survivors.

scientific article published on October 2011

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer.

scientific article

Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa.

scientific article

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.

scientific article

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels

scientific article published on 01 January 2002

Management of advanced breast cancer.

scientific article published on June 2007

Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients.

scientific article

Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity.

scientific article

Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer.

scientific article

Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects.

scientific article published in December 2005

Metronomic therapy and breast cancer: a systematic review.

scientific article published on 18 June 2014

Metronomics in the neoadjuvant and adjuvant treatment of breast cancer

scientific article published on 13 January 2017

Mitoxantrone, fluorouracil plus L-leucovorin, and vinorelbine in pretreated advanced breast cancer

scientific article published on 01 November 1995

Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer

scientific article published on 16 July 2015

Neoadjuvant chemotherapy for breast cancer: any progress?

scientific article

Neoadjuvant nab-paclitaxel in breast cancer: trial results and patient care

scientific article published on 08 February 2016

Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancer

scientific article published on 16 July 2010

Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response.

scientific article published on 8 February 2007

Nonrandomized comparison between concomitant and sequential chemoradiotherapy with anthracyclines in breast cancer.

scientific article

Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial

scientific article

Oesophageal cancer treatment: studies, strategies and facts

scientific article published on 01 September 1998

Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters: Is it Oncologically Safe? A Matched-Cohort Analysis.

scientific article published on 2 February 2016

Oral chemotherapy with doxifluridine and folinic acid in biliary tract cancer

scientific article published on 01 December 1995

Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort report.

scientific article published on 25 July 2012

Outcome and Medial Presentation of Breast Cancer: European Institute of Oncology Experience.

scientific article published on 10 July 2015

Outcome of male breast cancer: a matched single-institution series

scientific article published in March 2014

Outcomes of patients with breast cancer who present with ipsilateral supraclavicular or internal mammary lymph node metastases.

scientific article published on 27 September 2013

Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial.

scientific article

PET/CT and breast cancer subtypes.

scientific article

Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3).

scientific article published on July 2016

Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression

scientific article published on 18 July 2007

Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features.

scientific article published on 13 July 2010

Pathological features and survival outcomes of very young patients with early breast cancer: how much is "very young"?

scientific article published on 30 September 2013

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.

scientific article

Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer

scientific article published on 11 March 2011

Phase II Study With Epirubicin, Cisplatin, and Infusional Fluorouracil Followed by Weekly Paclitaxel With Metronomic Cyclophosphamide as a Preoperative Treatment of Triple-Negative Breast Cancer.

scientific article published on 18 March 2015

Phase II Study of Estramustine, Oral Etoposide, and Vinorelbine in Hormone-Refractory Prostate Cancer ⬇️

scientific article published on August 1, 1997

Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancer.

scientific article published on December 2010

Picking the optimal endocrine adjuvant treatment for pre-menopausal women

scientific article published on 3 August 2015

Positive axillary sentinel lymph node: is axillary dissection always necessary?

scientific article published on October 2011

Practical considerations in the treatment of hepatocellular carcinoma.

scientific article published on March 1998

Pre-operative chemotherapy and radiotherapy in breast cancer

scientific article published on 01 April 1998

Prediction of response to primary chemotherapy for operable breast cancer

scientific article published on 01 April 1999

Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab.

scientific article

Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.

scientific article published on 22 October 2015

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

scientific article published on 29 January 2008

Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phase.

scientific article published in October 2003

Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity.

scientific article published on 21 October 2008

Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptors

scientific article published in July 2008

Preoperative systemic treatment: prediction of responsiveness.

scientific article published on December 2003

Preoperative therapy with trastuzumab and oral vinorelbine (+/- endocrine therapy) in patients with HER2-positive breast cancer

scientific article published on 8 February 2010

Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)

scientific article published on 01 August 1999

Primary therapy with ECF in combination with a GnRH analog in premenopausal women with hormone receptor-positive T2–T4 breast cancer

scientific article published in February 2007

Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse.

scientific article

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.

scientific article published on 23 March 2010

Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes

scientific article published on 31 March 2011

Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.

scientific article published on 12 March 2009

Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancer.

scientific article published on 10 July 2014

Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer.

scientific article published on 22 August 2007

Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer

scientific article published on 01 September 2006

Prophylaxis for venous thromboembolism in cancer patients with a central vein catheter: new tones for an old song.

scientific article published in October 2005

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

scientific article

Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancer

scientific article published on 01 January 1993

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.

scientific article published on 27 November 2007

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

scientific article published on 10 April 2019

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents

scientific article

Receptor status (ER, PgR and HER2) discordance between primary tumor and locoregional recurrence in breast cancer

scientific article published on 01 February 2011

Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assay

scientific article published on 01 June 2002

Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index.

scientific article published in September 2005

Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial

scientific article

Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates

scientific article published on 23 May 2012

Reply to L. Moscetti

scientific article published on 17 January 2017

Reply to the article “Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity” by V. R. Rozados et al. (Ann Oncol 2004; 15: 1543–1550): … and in humans?

scientific article published on 16 February 2005

Research issues affecting preoperative systemic therapy for operable breast cancer.

scientific article published on February 2008

Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors

article

Results of a salvage regimen in refractory or relapsed non-Hodgkin's lymphoma

scientific article published on 01 June 1994

Results of chest wall resection for recurrent or locally advanced breast malignancies.

scientific article published on 12 February 2007

Robotic nipple-sparing mastectomy for the treatment of breast cancer: Feasibility and safety study

scientific article

Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy

scientific article published in September 2008

Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease

scientific article published on 23 June 2006

Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgery

scientific article published on 16 October 2006

Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial.

scientific article published on 25 January 2017

Sarcoidosis with bone involvement mimicking metastatic disease at (18)F-FDG PET/CT: problem solving by diffusion whole-body MRI.

scientific article published on 07 May 2015

Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of Oncology.

scientific article published on 17 December 2014

Sentinel lymph node biopsy is feasible even after total mastectomy

scientific article published on 01 February 2007

Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment

scientific article published on 25 December 2015

Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years

scientific article published on 01 February 2008

Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy

Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience.

scientific article published in March 2005

Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement.

scientific article published in March 2005

Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression

scientific article published on 26 October 2013

Symptoms of endocrine treatment and outcome in the BIG 1-98 study.

scientific article published on 05 December 2013

Systemic Effects of Surgery: Quantitative Analysis of Circulating Basic Fibroblast Growth Factor (bFGF), Vascular Endothelial Growth Factor (VEGF) and Transforming Growth Factor Beta (TGF-β) in Patients with Breast Cancer Who Underwent Limited or Ex

article

Systemic treatments for women with breast cancer: outcome with relation to screening for the disease.

scientific article

Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.

scientific article published on 7 December 2007

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

scientific article published on 04 June 2018

Tailoring adjuvant treatments for the individual patient with luminal breast cancer.

scientific article published on 18 June 2013

Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.

scientific article published on 27 February 2006

Targeting bone metastatic cancer: Role of the mTOR pathway

scientific article published on 05 February 2014

The aromatase inhibitors (plus ovarian function suppression) in premenopausal breast cancer patients: ready for prime time?

scientific article published on 29 May 2013

The clinical relevance of micropapillary carcinoma of the breast: a case-control study

scientific article

Time to initiation of adjuvant chemotherapy for early breast cancer and outcome: the earlier, the better?

scientific article published on 10 February 2014

Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor.

scientific article published on 7 April 2005

Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VII.

scientific article published on October 2016

Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy

scientific article published on 20 March 2010

Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy.

scientific article

Topoisomerase IIα gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer

article

Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence.

scientific article published on 23 May 2016

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

scientific article

Treatment of advanced breast cancer: the good, the bad and the ugly

scientific article published on 13 May 2005

Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

scientific article published on 09 April 2020

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.

scientific article published on 02 July 2016

Unfavorable prognostic role of tumor-infiltrating lymphocytes in hormone-receptor positive, HER2 negative metastatic breast cancer treated with metronomic chemotherapy

scientific article published on 22 May 2017

Unnecessary axillary node dissections in the sentinel lymph node era

scientific article published on 10 October 2007

Very young women (<35 years) with operable breast cancer: features of disease at presentation.

scientific article published in February 2002

Video-assisted management of malignant pleural effusion in breast carcinoma

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial.

scientific article

Whole-body magnetic resonance imaging, metastatic breast cancer and pregnancy: a case report

scientific article published on 13 February 2014

Paulina is supported by:

About Paulina

Help